Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Altimmune Inc (NASDAQ:ALT)

3.31
Delayed Data
As of 10:16am ET
 +0.02 / +0.61%
Today’s Change
2.77
Today|||52-Week Range
14.70
-13.82%
Year-to-Date
No recent news for Altimmune Inc.

Today’s Trading

Previous close3.29
Today’s open3.40
Day’s range3.30 - 3.45
Volume5,795
Average volume (3 months)145,926
Market cap$50.8M
Dividend yield--
Data as of 10:16am ET, 06/29/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-50.85%
P/E ratio1.1
Price/Sales40.80
Price/Book1.15

Competitors

 Today’s
change
Today’s
% change
ADMAADMA Biologics Inc-0.18-4.68%
KMPHKemPharm Inc+0.15+4.23%
APVOAptevo Therapeutics ...-0.03-1.18%
AKTXAkari Therapeutics P...+0.21+4.09%
Data as of 10:19am ET, 06/29/2017

Financials

Last reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$5.2M
Annual profit (last year)$193.9M
Net profit margin3,706.44%

Profile

Sector
Commercial Services
Industry
Miscellaneous Commercial Services
President, Chief Executive Officer &
Director
William Enright
CFO, Secretary &
EVP-Corporate Development
Elizabeth Adkins Czerepak
Corporate headquarters
Gaithersburg, Maryland

Forecasts